Answers are grounded in this paper and cite their sources.
Comparison of treatment-related adverse events with the combination of berzosertib and topotecan
No takes yet. Share an insight, caveat, or question.
Abel et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: